Daniel Arthur Ermann, George Dranitsaris, Sibel Blau, Aaron Peevyhouse, Heather Neuhalfen, Vikram Shetty, Svea K Wahlstrom, Samantha L. Thompson, Anna Teschemaker, Mayuer Narkhede. "A real-world comparative study of hypertension (HTN) and time to treatment failure (TTF) with acalabrutinib versus ibrutinib in treatment-naive Medicare-eligible patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e23279